Developing a Preferred Reporting Items for Development of Evidence based Clinical Practice Guideline in Traditional Medicine (PRIDE-CPG-TM)

Article type
Authors
Choi J1, Jun JH1, Lee JA1, Choi TY2, Lee MS2, Shin B3, Choi J2, Choi J2
1Korea Institute of Oriental Medicine, South Korea
2Korea Institute of Oriental Medicine, South Korea
3School of Korean Medicine, Pusan National University, South Korea
Abstract
Background: The development of evidence based clinical practice guidelines (CPGs) is a challenge for all guideline developers in traditional medicine. Using a publication platform with reporting items may overcome these challenges.
Objectives: The aim of this study was to develop a unified methods platform with preferred reporting items for development of evidence-based (PRIDE) clinical practice guidelines (CPG) in traditional medicine (TM).
Methods: We searched the literature and guideline handbooks, and collected information from methodological conferences. A group of experts edited drafts of the PRIDE, identifying for each item of one or more exemplars of good reporting, and developed text explaining the rationale and discussing relevant evidence. To develop the PRIDE, we also used general and various guideline checklists and drew on the experience gained from Oriental medical doctors and methodological experts.
Results: We designed the Preferred Reporting Items for Development of Evidence-based Clinical Practice Guidelines in Traditional Medicine (PRIDE-CPG-TM), in the form of a checklist with descriptions of items and examples, to improve reporting of CPG in TM, and so facilitate their interpretation and replication. The PRIDE included five items and 40 sub-items. These items pertain to the development methodology (22 items), overview of diseases and symptoms (six items), recommendations (four items), implementation and dissemination (five items) and the appendix (three items, i.e. glossary, references etc.).
Conclusions: The completeness of descriptions in CPGs is very poor. Therefore, a complete description of the recommendation of TM in CPGs is necessary for physicians to be able to use the recommendations in areas of clinical practice. The PRIDE will be useful guidance for TM developers when developing evidence-based guidelines.